The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools
Net Asset AnalysisNet Asset is current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assest is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
About Net AssetNet Asset is the value used in calulating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formullay that uses closing prices of all positions in the fund's portfolio.
|Compare to competition|
Based on recorded statements BioShares Biotechnology Products has Net Asset of 38.48 M. This is 64.23% higher than that of the Bio Shares family, and 64.23% higher than that of Health category, The Net Asset for all etfs is 95.67% higher than the company.